Commentary on Resveratrol and Hormesis: Resveratrol - A hormetic marvel in waiting?

Human and Experimental Toxicology

Volumn 29, Issue 12, 2010, Pages 1026-1028

  Marques, Francine Z ^a   Morris, Brian J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

co morbidities; doses; hormesis; interaction; resveratrol

Indexed keywords

ALCOHOL; DIMETHYL SULFOXIDE; NON PRESCRIPTION DRUG; RESVERATROL; SIRTUIN 1;

CANCER CELL; CANCER RISK; CELL INTERACTION; CELL PROLIFERATION; CELL TYPE; COMORBIDITY; DIETARY INTAKE; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; ENVIRONMENTAL FACTOR; HORMESIS; HUMAN; IMMUNE RESPONSE; INTRACELLULAR SPACE; NEOPLASM; NOTE; OSTEOPOROSIS; OVARY CARCINOMA; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANIMALS; BIOLOGICAL AVAILABILITY; BIOMEDICAL RESEARCH; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NONPRESCRIPTION DRUGS; SOLUBILITY; STILBENES;

ANIMALIA;

EID: 78649970631     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110383640     Document Type: Note

References (16)

1. Morris BJ How xenohormetic compounds confer health benefits. In: Le Bourg E, Rattan S (eds) Mild stress: applying hormesis in aging research and interventions. Netherlands: Springer, 2008, p. 115-138.
2. Marques FZ, Markus MA, and Morris BJ Hormesis as a pro-healthy aging intervention in human beings ? Dose Response 2009 ; 8: 28-33.
3. Markus MA, Morris BJ Resveratrol in prevention and treatment of common clinical conditions of aging. Clin Interv Aging 2008 ; 3: 331-339.
4. Marques FZ, Markus MA, and Morris BJ Resveratrol: cellular actions of a potent natural chemical that confers a diversity of health benefits. Int J Biochem Cell Biol 2009 ; 41: 2125-2128.
5. Morris BJ Calorie restriction mimetics and ageing. In: Everitt AV, Rattan S, Le Couteur DG, and de Cabo R (eds) Calorie Restriction, Aging and Longevity. Springer, 2010, pp 141-175.
6. Baur JA, Sinclair DA Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006 ; 5: 493-506.
7. Stefani M., Markus MA, Lin RC, Pinese M., Dawes IW, Morris BJ The effect of resveratrol on a cell model of human aging. Ann N Y Acad Sci 2007 ; 1114: 407-418.
8. Calabrese EJ, Mattson MP, and Calabrese V. Resveratrol commonly displays hormesis: occurrence and biomedical significance. Hum Exp Toxicol 2010 ; 29: 980-1015.
9. Ledford H. Much ado about ageing. Nature 2010 ; 464: 480-481.
10. Haigis MC, Sinclair DA Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 2010 ; 5: 253-95.
11. Boffetta P., Couto E., Wichmann J., Ferrari P., Trichopoulos D., Bueno-de-Mesquita HB, et al. Fruit and vegetable intake and overall cancer risk in the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst 2010 ; 102: 529-537.
12. Morris BJ Climate not cultivars in the NO-ing of red wines. J Hypertens 2007 ; 25: 501-503.
13. Elliott PJ, Walpole S., Morelli L., Lambert PD, Lunsmann W., Westphal CH, Lavu S. Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev 2010 ; 131: 261-269.
14. Elliott PJ, et al. Resveratrol/SRT-501. Drugs Fut 2009 ; 34: 291.
15. Smith JJ, Kenney RD, Gagne DJ, Frushour BP, Ladd W., Galonek HL, et al. Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo. BMC Syst Biol 2009 ; 3: 31.
16. Rodriguez-Burford C., Oelschlager DK, Talley LI, Barnes MN, Partridge EE, Grizzle WE The use of dimethylsulfoxide as a vehicle in cell culture experiments using ovarian carcinoma cell lines. Biotech Histochem 2003 ; 78: 17-21.